Mesenchymal Cell News Volume 7.15 | Apr 21 2015

    0
    17
    Mesenchymal Cell News 7.15 April 21, 2015

    Mesenchymal Cell News

         In this issue: Publications | Reviews | Industry News | Policy News | Events | Jobs
    Cell Therapy News on Facebook   MESCN on Twitter

     
    TOP STORY
    NOX1-Induced Accumulation of Reactive Oxygen Species in Abdominal Fat-Derived Mesenchymal Stromal Cells Impinges on Long-Term Proliferation
    Repeated attempts to produce long-term proliferative cultures of rat abdominal adipose stem cells (aASCs) under normal oxygen concentration were unsuccessful. The authors set to examine the events controlling this cytostasis of aASCs and found that it resulted from overproduction of reactive oxygen species that led to apoptosis. [Cell Death Dis] Full Article
    FREE Webinar: Tips & Techniques for Highly Enriched Mouse MSC Cultures as Early as Passage 0

     
    PUBLICATIONS (Ranked by impact factor of the journal)
    Phenotypic and Functional Characterization of Long-Term Cryopreserved Human Adipose-Derived Stem Cells
    Human adipose-derived stem cells (ASCs) were preserved for three months in different combinations of cryoprotective agents. Cryopreserved ASCs maintained high cell viability comparable with standard cryomedium, with normal cell phenotype and proliferation rate. Cryopreserved ASCs also maintained their differentiation capability and showed an enhanced expression level of stemness markers. [Sci Rep] Full Article

    Microencapsulated Equine Mesenchymal Stromal Cells Promote Cutaneous Wound Healing In Vitro
    Researchers evaluated the in vitro effects of equine mesenchymal stromal cells (MSC)-derived conditioned medium (CM), containing all factors secreted by MSC, on equine dermal fibroblasts, a cell type critical for successful wound healing, and explored the potential of microencapsulated equine MSC to deliver CM to wounded cells in vitro. [Stem Cell Res Ther] Abstract | Full Article

    Mouse Aorta-Derived Mesenchymal Progenitor Cells Contribute to and Enhance the Immune Response of Macrophage Cells under Inflammatory Conditions
    To examine the consequence of vascular-tissue progenitor cell-macrophage cell interactions in an inflammatory environment, researchers used a recently established mesenchymal progenitor cell line derived from the mouse aorta. [Stem Cell Res Ther] Abstract | Full Article

    Effect of Organic Acids on Calcium Phosphate Nucleation and Osteogenic Differentiation of Human Mesenchymal Stem Cells on Peptide Functionalized Nanofibers
    Scientists investigated the effect of organic acids on calcium phosphate (CaP) nucleation on nanofiber microsheets functionalized with a glutamic acid peptide and osteogenic differentiation of human mesenchymal stem cells seeded on the CaP-nucleated microsheets. [Langmuir] Abstract

    The Effects of Naproxen on Chondrogenesis of Human Mesenchymal Stem Cells
    Scientists determined the effect of Naproxen on collagen type X gene expression and investigated the intracellular signaling pathways that mediate such effect in normal human mesenchymal stem cells during chondrogenesis. [Tissue Eng Part A] Abstract

    Human Vascular Wall Mesenchymal Stromal Cells Contribute to Abdominal Aortic Aneurysm Pathogenesis through an Impaired Immunomodulatory Activity and Increased Levels of Matrix Metalloproteinase-9
    Investigators verified the presence and contribution of mesenchymal stromal cells (MSCs) to aneurysmal tissue remodeling. MSCs were successfully isolated from the abdominal aortic aneurysm wall of 12 male patients and were found to express mesenchymal and stemness markers. [Circ J] Full Article

    Simvastatin Modulates Mesenchymal Stromal Cell Proliferation and Gene Expression
    The authors showed that simvastatin negatively modulates mesenchymal stromal cell (MSC) proliferation in a dose-dependent way and regulates the expression of proliferation-related genes. They observed that simvastatin increased the percentage of a subset of smaller MSCs, which also were actively proliferating. [PLoS One] Full Article

    TAp63γ and ΔNp63β Promote Osteoblastic Differentiation of Human Mesenchymal Stem Cells: Regulation by Vitamin D3 Metabolites
    Researchers compared the endogenous expression of p63 isoforms (TA- and ΔNp63) and splice variants (p63α, -β, -γ), in naive human mesenchymal stem cells (hMSC) and during osteoblastic differentiation of hMSC. TAp63α and -β were the predominant p63 variants in naive, proliferating hMSC. In contrast, under osteoblastic differentiation conditions, expression of p63 changed from the TAp63α and -β to the TAp63γ and ΔNp63β variants. [PLoS One] Full Article

    Enter to Win a Travel Support Award to ISSCR2015!

     
    REVIEWS
    Mechanobiology of Mesenchymal Stem Cells: A New Perspective into the Mechanically Induced MSC Fate
    The authors discuss the most recent advances that show applied forces and cell-generated forces may be engineered to determine mesenchymal stem and stromal cell (MSC) fate, and give an overview of a subset of the operative signal transduction mechanisms and experimental platforms that have emerged in MSC mechanobiology research. [Acta Biomater] Abstract

    Mesenchymal Stem Cell Based Therapy for Non-Healing Wounds: Today and Tomorrow
    The authors summarize the mechanisms of mesenchymal stem cells (MSCs) and highlight the important preclinical and clinical trials of MSC therapy for non-healing wounds. [Wound Repair Regen] Abstract

    Visit our reviews page to see a complete list of reviews in the mesenchymal cell research field.

     
    INDUSTRY NEWS
    Cord Blood Registry® Uses BioLife Solutions CryoStor® Clinical Grade Freeze Media in the Storage of Umbilical Cord Tissue Stem Cells
    BioLife Solutions, Inc. announced that Cord Blood Registry uses BioLife’s CryoStor clinical grade cryopreservation freeze media in its process for cryogenic storage of umbilical cord tissue stem cells. [BioLife Solutions, Inc.] Press Release

    Mount Sinai Receives $8.8 Million Grant to Further Stem Cell Research
    An $8.8 million grant from the New York State Stem Cell Science Program will accelerate efforts by the Icahn School of Medicine at Mount Sinai to develop new stem-cell-based treatments for chemotherapy-resistant blood cancer and other genetic blood disorders. [Icahn School of Medicine at Mount Sinai] Press Release

    From our sponsor: Learn about assays for cord blood. Download the free technical bulletin.

     
    POLICY NEWS
    National Institutes of Health (United States)

    Food and Drug Administration (United States)

    Center for Biologics Evaluation and Research (United States)

    European Medicines Agency (European Union)

    Medicines and Healthcare Products Regulatory Agency (United Kingdom)

    Therapeutic Goods Administration (Australia)

     
    EVENTS
    NEW Stem Cells & Regenerative Medicine Congress USA
    September 2-3, 2015
    Washington D.C., United States

    NEW Cell Therapy Bioprocessing & Commercialization
    September 30-October 1, 2015
    Alexandria, United States

    Visit our events page to see a complete list of events in the mesenchymal cell community.

     
    JOB OPPORTUNITIES
    NEW Assistant/Associate/Full Professor – Stem Cell Biology & Regenerative Medicine (University of Illinois Chicago College of Medicine)

    Research Associate: Mesenchymal (STEMCELL Technologies Inc.)

    Scientist – Myogenic Progenitor Cell Biology (STEMCELL Technologies Inc.)

    PhD Position – Biomaterials & Regenerative Medicine (Florida Atlantic University)

    Faculty Positions – Stem Cell & Regenerative Medicine (The University of Texas Medical School at Houston)

    Postdoctoral Position – Stem Cells (Technion – Israel Institute of Technology)

    PhD Positions – Cartilage Regeneration in Joints and Intervertebral Disc Diseases (AO Research Institute)

    Postdoctoral Fellowship – Hematology, Immunology, Stem Cell Transplantation, Cancer Therapeutics (The Research Institute at Nationwide Children’s Hospital)

    Cell Culture Specialist – Mesenchymal Stem Cell and Neural Stem Cell Cultures (Tisch MS Research Center of New York)

    Postdoctoral Fellow/Research Associate – Leukemia, Stem Cells and Development (Josep Carreras Leukemia Research Institute)


    Recruit Top Talent: Reach more than 60,000 potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.

     

    Have we missed an important article or publication in Mesenchymal Cell News? Click here to submit!

    Comments or suggestions? Submit your feedback here

    Learn more about Mesenchymal Cell News: Archives | Events | Contact Us